30 août 2026•1 min de lecture
FDA Approves Labeling for Norethindrone/Ethinyl Estradiol Tablet (ANDA078379)
The FDA approved labeling submissions for the oral tablet containing norethindrone 0.4 mg and ethinyl estradiol 0.035 mg (ANDA078379) submitted by Watson Labs.